tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
Pharvaris (PHVS)
NASDAQ:PHVS
PHVS
Pharvaris
Stock Analysis
Analyst Forecasts
Technical Analysis
Chart
Earnings
Dividends
Ownership
Financials
News & Insights
Similar Stocks
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports

Pharvaris (PHVS) Stock News & Sentiment

59 Followers
Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
PremiumCompany Announcements
Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
13d ago
PHVS
Pharvaris Excels in HAE Treatment Advances
PremiumCompany Announcements
Pharvaris Excels in HAE Treatment Advances
14d ago
6K
PHVS
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
15d ago
PHVS
Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
PremiumPress Releases
Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer
15d ago
PHVS
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
PremiumPress Releases
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
21d ago
PHVS
Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
PremiumPress Releases
Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses
1M ago
PHVS
Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
PremiumPress Releases
Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
2M ago
PHVS
More PHVS News >

PHVS News on the Web

Pharvaris N.V.’s High-Stakes Gamble: Navigating Clinical Trials and Regulatory Hurdles for Market Success
TipRanks News
Neutral
Buy Rating Affirmed for Pharvaris on Strong Clinical Progress and Financial Stability
TipRanks News
Bullish
PHVS Stock Earnings: Pharvaris Misses EPS for Q4 2023
InvestorPlace
Neutral
Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Yahoo Finance
Neutral
Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference
Yahoo Finance
Neutral
Analysts Offer Insights on Healthcare Companies: Pharvaris (PHVS), Alpine Immune Sciences (ALPN) and IGM Biosciences (IGMS)
TipRanks News
Bullish
Pharvaris Buy Rating Affirmed Amid Promising Phase 3 HAE Trial Prospects
TipRanks News
Bullish
Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
PHVS
Sector Average
Media Buzz
This Week4 articles
Weekly Average1.25 articles
News Sentiment
This Week100%
Sector Average65%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PHVS’s Media Buzz Sentiment?
4 articles about PHVS were published this week. In an average week, 1.25 articles are published.
    What is PHVS’s weekly average amount of articles?
    In an average week, 1.25 articles about PHVS are published.
      What is PHVS’s News Sentiment?
      100% of articles about PHVS were positive this week, compared to its sector average of 65%.
        Healthcare Stocks that are Trending in the News
        0HNZFagron SA
        ALPNAlpine Immune Sciences
        JANXJanux Therapeutics Inc
        SIGASIGA Technologies
        INNMFAmplia Therapeutics Ltd.
        Showing the stocks with the most bullish news sentiment over the past week

        Get More with TipRanks Premium

        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing